Description
Chai Discovery is at the forefront of artificial intelligence applications in drug discovery, focusing on predicting and reprogramming the interactions between biochemical molecules. The company is committed to engineering molecules using AI, which allows scientists to design new medicines directly on the computer, significantly speeding up the drug development process.
Read More
The platform is designed to cater to the needs of the world's leading life sciences companies, enabling them to move faster and pursue targets that traditional methods cannot reach. Chai Discovery has recently announced a Series C funding round, raising $400 million to accelerate their innovative work in this field.
Chai Discovery builds a comprehensive computer-aided design suite for molecules, leveraging models that learn the underlying foundations of biochemical structure and interaction. This capability is crucial for drug discovery, as it allows for the design of drug-like antibodies with atomic precision against challenging targets. The platform supports various antibody formats and achieves high success rates, particularly for miniproteins, which can bypass traditional screening methods.
The company has established collaborations with major pharmaceutical firms such as Novartis, Pfizer, Eli Lilly, and argenx, focusing on advancing AI-driven antibody discovery and immunology breakthroughs. These partnerships highlight the effectiveness of Chai Discovery's technology in addressing complex challenges in drug development.
Chai Discovery is also committed to making its technology accessible for both commercial and academic use, providing opportunities for organizations to leverage their AI models for innovative research and development. As they continue to build a future where new medicines can be designed with the precision and speed of modern engineering, Chai Discovery invites contributions from those interested in tackling one of the most meaningful challenges in AI.
- CategoryScientific Discovery & Lab Tools
- Pricing ModelFreemium
- DeploymentCloud
- PlatformsWeb
Chai Discovery's Core Features
De novo protein design that works reliably
Specify antibody format
Achieve high success rates for antibodies and miniproteins
Faster experimentation cycles in under 2 weeks
Prompt with any target using public or private structures
Target specific antigen confirmations
Address challenging targets without lab-based workarounds
Design for epitope specificity
Handle chemical modifications
Specify advanced design criteria
How to use Chai Discovery?
Specify antibody format: Choose the desired antibody format for your project.
Use public or private structures: Input the sequence or structure for the target.
Design for specific targets: Utilize the platform to target specific antigen confirmations.
Characterize in under 2 weeks: Move directly to characterization without high-throughput screening.
Chai Discovery's Use Cases
- Antibody Design
- Drug Discovery
- Immunology Research
- Biochemical Interaction Prediction
- Molecular Engineering
